Goldman Sachs’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $407K | Buy |
|
|||||
|
2025
Q2 | $328K | Sell |
|
|||||
|
2025
Q1 | $620K | Buy |
|
|||||
|
2024
Q4 | $560K | Buy |
|
|||||
|
2024
Q3 | $290K | Buy |
|
|||||
|
2024
Q2 | $199K | Sell |
|
|||||
|
2024
Q1 | $466K | Buy |
|
|||||
|
2023
Q4 | $208K | Buy |
|
|||||
|
2023
Q3 | $83.3K | Sell |
|
|||||
|
2023
Q2 | $437K | Sell |
|
|||||
|
2023
Q1 | $282K | Buy |
|
|||||
|
2022
Q4 | $443K | Sell |
|
|||||
|
2022
Q3 | $728K | Buy |
|
|||||
|
2022
Q2 | $785K | Sell |
|
|||||
|
2022
Q1 | $1.02M | Sell |
|
|||||
|
2021
Q4 | $1.08M | Buy |
|
|||||
|
2021
Q3 | $338K | Sell |
|
|||||
|
2021
Q2 | $1.04M | Sell |
|
|||||
|
2021
Q1 | $1.53M | Sell |
|
|||||
|
2020
Q4 | $2.69M | Buy |
|
|||||
|
2020
Q3 | $2.02M | Buy |
|
|||||
|
2020
Q2 | $1.59M | Buy |
|
|||||
|
2020
Q1 | $1.03M | Buy |
|
|||||
|
2019
Q4 | $1.3M | Buy |
|
|||||
|
2019
Q3 | $722K | Buy |
|
|||||
|
2019
Q2 | $346K | Sell |
|
|||||
|
2019
Q1 | $588K | Sell |
|
|||||
|
2018
Q4 | $738K | Buy |
|
|||||
|
2018
Q3 | $827K | Buy |
|
|||||
|
2018
Q2 | $454K | Sell |
|
|||||
|
2018
Q1 | $702K | Sell |
|
|||||
|
2017
Q4 | $716K | Sell |
|
|||||
|
2017
Q3 | $741K | Buy |
|
|||||
|
2017
Q2 | $782K | Buy |
|
|||||
|
2017
Q1 | $577K | Buy |
|
|||||
|
2016
Q4 | $631K | Buy |
|
|||||
|
2016
Q3 | $550K | Buy |
|
|||||
|
2016
Q2 | $212K | Buy |
|
|||||
|
2016
Q1 | $202K | Sell |
|
|||||
|
2015
Q4 | $244K | Sell |
|
|||||
|
2015
Q3 | $265K | Buy |
|
|||||
|
2015
Q2 | $213K | Sell |
|
|||||
|
2015
Q1 | $295K | Sell |
|
|||||
|
2014
Q4 | $351K | Sell |
|
|||||
|
2014
Q3 | $349K | Buy |
|
|||||
|
2014
Q2 | $340K | Sell |
|
|||||
|
2014
Q1 | $347K | Sell |
|
|||||
|
2013
Q4 | $789K | Buy |
|
|||||
|
2013
Q3 | $649K | Sell |
|
|||||
|
2013
Q2 | $748K | Buy |
|